Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Gorodissky & PartnersVladimir Biriulin of Gorodissky & Partners discusses a trademark dispute ruling by the Chamber of Patent Disputes, concerning amendments to invention applications -
Sponsored by MaiwaldEva Ehlich and Angela Zumstein of Maiwald explore why video conference technology at the EPO has caused widespread concern
-
Sponsored by Tilleke & GibbinsSuebsiri Taweepon and Ploynapa Julagasigorn of Tilleke & Gibbins discuss the amendments to Thailand’s Copyright Act that copyright owners, legal practitioners and internet service providers should be aware of
-
Sponsored by Daniel LawAndré Oliveira of Daniel Law considers how IP infringement and brand protection has evolved in Brazil amid the pandemic
-
Sponsored by Patrinos & KilimirisConstantinos Kilimiris of Patrinos & Kilimiris explains how a recent amendment in the provisions of the Greek patent law resolves a long-standing issue which prevented amending applications
-
Sponsored by AJ ParkAJ Park looks at the ASA’s recent Rangiora decision and its impact on the revitalisation of the Māori language in New Zealand
